Firm Record

Mera Cannabis Corp. findings history

12 findings from 3 inspection documents published by regulators. Each row below says what its date means.

EMA (Europe)Health Canada 2025-06-24 ~ 2026-06-02 3 documents 12 findings

Areas cited

Regulatory reporting and change controlOther quality systemData integrityEquipment and facilityLaboratory and QC controlsMaterial and supplier controlDeviation, CAPA, and investigationComputer system validation

Published inspection documents

2026-06-02 Health Canada 7 findingsLaboratory and QC controls · Material and supplier control · Equipment and facility The quality control department's release of packaging materials for use in packaging or labelling was inadequate. 2025-09-11 EMA (Europe) 1 findingsData integrity The inspection was conducted between 24th and 30th of July 2025. During the inspection ten major findings were observed, whereas one major finding was related to an external warehouse, which was not finalized yet and has no impact on the current production, and one was related to the process validation of planned products. The other major findings were related to the purchase of dried cannabis flowers from non-GMP facilities, to a missing calibrated and validated monitoring system for environmental conditions, to stability studies, to a non-functional management system for documents, samples, equipment and products, to data integrity and to qualification of facilities. Partially, it was conducted that not all corrective actions of observations from the initial inspection were taken although these were confirmed by the company. Therefore, a follow-up inspection is necessary. Action taken/proposed by the NCA: Recall of batches already released Since the certificate was issued, several batches have been imported into the EU. The decision on a recall is at the discretion of the respective competent authorities. The competent authority of Berlin decided to recall the only batch from the market that was imported so far from the Berlin importer. Since only one pharmacy was affected, no Rapid Alert Notification was issued. Prohibition of supply No further batches should be imported and supplied to the market until GMP compliance was confirmed through an inspection. 2025-06-24 Health Canada 4 findingsDeviation, CAPA, and investigation · Regulatory reporting and change control · Other quality system · Computer system validation Investigations into deviations, reports, and/or follow-up actions were inadequate.

About this page

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

What is included. As of 2026-09-03, only documents that have a detail page (at least 3 findings) are listed. The company may have more documents; the full set is available in Company lookup below.

Companies are grouped by a normalised key, not the displayed name — “… Limited” and “… Ltd.” count as the same company. Translation and classification are automated and may differ in nuance from the source; the basis for judgement is always the regulator's published document.

Full history of Mera Cannabis Corp. — including inspection classifications Browse by document Go to Findings search